Treace Medical Concepts, Inc. Common Stock (TMCI) is a publicly traded Healthcare sector company. As of July 24, 2026, TMCI trades at $3.99 with a market cap of $257.55M and a P/E ratio of -4.16. TMCI moved -0.99% today. Year to date, TMCI is +65.31%; over the trailing twelve months it is -33.39%. Its 52-week range spans $1.17 to $10.79. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces TMCI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover TMCI: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $5.50.
| Metric | Value |
|---|---|
| Price | $3.99 |
| Market Cap | $257.55M |
| P/E Ratio | -4.16 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.79 |
| 52-Week Low | $1.17 |
| Volume | 8.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $207.32M |
| Net Income | $-61.04M |
| Gross Margin | 79.72% |
2 analysts cover TMCI: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.